Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review

Document Sample
Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					                Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT
                                       Analysis Review

       Reference Code: GDME7173FSA                                                                                      Publication Date: APR 2011

       1 Corporate Avenue                 Phone            +61 3 92139000                                 Revenue           18 (million AUD)
       Rowville, VIC                      Fax              +61 3 92136490                                 Net Profit        -6.61 (million AUD)
       3149                               Website          www.universalbiosensors.com                    Employees         95
       Australia                          Exchange         UBI [Australian Stock Exchange (Sydney)] Industry                Medical Equipment

      Company Overview
       Universal Biosensors, Inc. (Universal Biosensors) is a medical diagnostics company engaged in the research, development,
       manufacture and commercialization of in vitro diagnostic tests for point of care market. The diagnostic tests consist of a novel
       disposable test strip and a reusable meter. It develops point of care blood tests such as C-reactive protein test, D-dimer test and
       Prothrombin time test. The company uses electrochemical cell technology for the development of point of care tests. Universal
       Biosensors is headquartered in Victoria, Australia.

      Key Executives                                                              SWOT Analysis
                     Name                                  Title                  Universal Biosensors, Inc., SWOT Analysis
       Andrew Denver                        Chairman                              Strengths                     Weaknesses

       Colin Adam, Ph.D.                    Director
                                                                                  Focused Research and                 Low Return on Equity
       Denis Hanley                         Director                              Development Activities
       Andrew Jane                          Director                                                                   Single Manufacturing Facility
                                                                                  Novel Strip and Meter
       Marshall Heinberg                    Director                              Technologies
       Source: Annual Report, Company Website, Primary and Secondary Research,
       GlobalData

      Share Data
                                                                                  Opportunities                        Threats
       Universal Biosensors, Inc.
                                                                          1.31    Growth in Emerging                   Dependence on Single
                                                                                  Economies                            Customer
       EPS (AUD)                                                            NA

       Market Cap (million AUD)                                             NA    New Product Launches                 Regulatory Clearances
       Enterprise Value (million AUD)                                       NA

       Shares Outstanding (million)                                        159
       Source: Annual Report, Company Website, Primary and Secondary Research,    Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                  GlobalData
       GlobalData

      Financial Performance                                                       Recent Developments
                                                                                  Sep 09, 2010         Universal     Biosensors      Announces
                                                                                                       Retirement Of Mark Morrisson As CEO
                                                                                  Aug 09, 2010         Universal  Biosensors    Reports    Total
                                                                                                       Revenues Of AUD2.76 Million In Q2 2010
                                                                                  Mar 16, 2010         Universal Biosensors Reports Net Profit Of
                                                                                                       AUD1.4 Million In 2009
                                                                                  Jan 28, 2010         LifeScan Launches One Touch Verio In
                                                                                                       Netherlands
                                                                                  Jan 11, 2010         Universal Biosensors Announces Board
        Source: Annual Report, Company Website, Primary and Secondary Research,                        Changes
        GlobalData                                                                Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                  GlobalData




Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis                                                         Reference Code: GDME7173FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                  Page 1
      Table of Contents
      Table of Contents........................................................................................................................................................................................................... 2
      List of Tables .................................................................................................................................................................................................................. 4
      List of Figures................................................................................................................................................................................................................. 4
      Section 1 - About the Company ..................................................................................................................................................................................... 5
      Universal Biosensors, Inc. - Key Facts .......................................................................................................................................................................... 5
      Universal Biosensors, Inc. - Key Employees ................................................................................................................................................................. 6
      Universal Biosensors, Inc. - Key Employee Biographies ............................................................................................................................................... 7
      Universal Biosensors, Inc. - Major Products and Services ............................................................................................................................................ 8
      Universal Biosensors, Inc. - Medical Equipment Pipeline Products Data ...................................................................................................................... 9
            Universal Biosensors, Inc. Pipeline Products by Equipment Type .......................................................................................................................... 9
            Universal Biosensors, Inc. Pipeline Products by Development Stage................................................................................................................... 11
      Universal Biosensors, Inc. - History ............................................................................................................................................................................. 13
      Universal Biosensors, Inc. - Company Statement........................................................................................................................................................ 14
      Universal Biosensors, Inc. - Locations And Subsidiaries ............................................................................................................................................. 15
            Head Office............................................................................................................................................................................................................ 15
      Section 2 – Company Analysis .................................................................................................................................................................................... 16
      Universal Biosensors, Inc. - Business Description....................................................................................................................................................... 16
      Universal Biosensors, Inc. - Corporate Strategy .......................................................................................................................................................... 17
      Universal Biosensors, Inc. - SWOT Analysis ............................................................................................................................................................... 18
            SWOT Analysis - Overview ................................................................................................................................................................................... 18
            Universal Biosensors, Inc. - Strengths................................................................................................................................................................... 18
                  Strength - Focused Research and Development Activities............................................................................................................................. 18
                  Strength - Novel Strip and Meter Technologies .............................................................................................................................................. 18
                  Strength - Strong Liquidity Position................................................................................................................................................................. 18
                  Strength - Expanding Market Share in the Sector........................................................................................................................................... 18
                  Strength - Agreement with LifeScan ............................................................................................................................................................... 19
            Universal Biosensors, Inc. - Weaknesses ............................................................................................................................................................. 19
                  Weakness - Low Return on Equity.................................................................................................................................................................. 19
                  Weakness - Single Manufacturing Facility ...................................................................................................................................................... 19
            Universal Biosensors, Inc. - Opportunities............................................................................................................................................................. 19
                  Opportunity - Growth in Emerging Economies................................................................................................................................................ 19
                  Opportunity - New Product Launches ............................................................................................................................................................. 20
                  Opportunity - Growing Point-of-Care Testing Market...................................................................................................................................... 20
                  Opportunity - Growing Older Population ......................................................................................................................................................... 20
                  Opportunity - Rising Healthcare Expenditure in the US .................................................................................................................................. 20
            Universal Biosensors, Inc. - Threats...................................................................................................................................................................... 21
                  Threat - Dependence on Single Customer...................................................................................................................................................... 21
                  Threat - Regulatory Clearances ...................................................................................................................................................................... 21
                  Threat - Intense Competition........................................................................................................................................................................... 21
      Universal Biosensors, Inc. - Key Competitors.................
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:36
posted:8/16/2010
language:English
pages:36
Description: Universal Biosensors, Inc. (UBI) - Financial and Strategic SWOT Analysis Review Summary Universal Biosensors, Inc. (Universal Biosensors) is a medical diagnostics company engaged in the research, development, manufacture and commercialization of in vitro diagnostic tests for point of care market. The diagnostic tests consist of a novel disposable test strip and a reusable meter. It develops point of care blood tests such as C-reactive protein test, D-dimer test and Prothrombin time test. The company uses electrochemical cell technology for the development of point of care tests. Universal Biosensors is headquartered in Victoria, Australia. Universal Biosensors, Inc. Key Recent Developments… Sep 09, 2010: Universal Biosensors Announces Retirement Of Mark Morrisson As CEO Aug 09, 2010: Universal Biosensors Reports Total Revenues Of AUD2.76 Million In Q2 2010 Mar 16, 2010: Universal Biosensors Reports Net Profit Of AUD1.4 Million In 2009 Jan 28, 2010: LifeScan Launches One Touch Verio In Netherlands Jan 11, 2010: Universal Biosensors Announces Board Changes This comprehensive SWOT profile of Universal Biosensors, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the comp
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.